These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35844683)

  • 1. RUNX inhibitor suppresses graft-versus-host disease through targeting
    Kubota H; Masuda T; Noura M; Furuichi K; Matsuo H; Hirata M; Kataoka TR; Hiramatsu H; Yasumi T; Nakahata T; Imai Y; Takita J; Adachi S; Sugiyama H; Kamikubo Y
    EJHaem; 2021 Aug; 2(3):449-458. PubMed ID: 35844683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2022 Sep; 620():150-157. PubMed ID: 35792512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Alkylation of the RUNX-Binding Sequence by CBI-PI Polyamide Conjugates*.
    Maeda R; Ito S; Hashiya K; Bando T; Sugiyama H
    Chemistry; 2020 Nov; 26(64):14639-14644. PubMed ID: 32672369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.
    Mikami M; Masuda T; Kanatani T; Noura M; Umeda K; Hiramatsu H; Kubota H; Daifu T; Iwai A; Hattori EY; Furuichi K; Takasaki S; Tanaka S; Matsui Y; Matsuo H; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Imai Y; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Mol Cells; 2022 Dec; 45(12):886-895. PubMed ID: 36572559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic regulation of the RUNX transcription factor family has antitumor effects.
    Morita K; Suzuki K; Maeda S; Matsuo A; Mitsuda Y; Tokushige C; Kashiwazaki G; Taniguchi J; Maeda R; Noura M; Hirata M; Kataoka T; Yano A; Yamada Y; Kiyose H; Tokumasu M; Matsuo H; Tanaka S; Okuno Y; Muto M; Naka K; Ito K; Kitamura T; Kaneda Y; Liu PP; Bando T; Adachi S; Sugiyama H; Kamikubo Y
    J Clin Invest; 2017 Jun; 127(7):2815-2828. PubMed ID: 28530640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chb-M', an Inhibitor of the RUNX Family Binding to DNA, Induces Apoptosis in
    Hirose Y; Sato S; Hashiya K; Ooga M; Bando T; Sugiyama H
    J Med Chem; 2024 Jun; 67(11):9165-9172. PubMed ID: 38803164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Characteristics of DNA-Alkylating PI Polyamides Targeting RUNX Transcription Factors.
    Maeda R; Sato S; Obata S; Ohno T; Hashiya K; Bando T; Sugiyama H
    J Am Chem Soc; 2019 Mar; 141(10):4257-4263. PubMed ID: 30601664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition.
    Daifu T; Mikami M; Hiramatsu H; Iwai A; Umeda K; Noura M; Kubota H; Masuda T; Furuichi K; Takasaki S; Noguchi Y; Morita K; Bando T; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28789. PubMed ID: 33180377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
    Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
    Front Immunol; 2021; 12():785774. PubMed ID: 34987512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect.
    Bernardi C; Charvet C; Zeiser R; Simonetta F
    Transplant Cell Ther; 2024 Apr; 30(4):386-395. PubMed ID: 38224950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation.
    Kaminski BA; Kadereit S; Miller RE; Leahy P; Stein KR; Topa DA; Radivoyevitch T; Veigl ML; Laughlin MJ
    Blood; 2003 Dec; 102(13):4608-17. PubMed ID: 12946996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157].
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2023 May; 656():146-147. PubMed ID: 36966045
    [No Abstract]   [Full Text] [Related]  

  • 13. Early myeloid-derived suppressor cells (HLA-DR
    Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.
    Hatano R; Itoh T; Otsuka H; Saeki H; Yamamoto A; Song D; Shirakawa Y; Iyama S; Sato T; Iwao N; Harada N; Aune TM; Dang NH; Kaneko Y; Yamada T; Morimoto C; Ohnuma K
    Am J Transplant; 2022 Dec; 22(12):2804-2820. PubMed ID: 35997569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
    Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer Activities of DNA-Alkylating Pyrrole-Imidazole Polyamide Analogs Targeting RUNX Transcription Factors against
    Hirose Y; Sato S; Hashiya K; Bando T; Sugiyama H
    J Med Chem; 2023 Sep; 66(17):12059-12068. PubMed ID: 37606185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-way translocation (X;20;16)(p11;q13;q23) in essential thrombocythemia implicates NFATC2 in dysregulation of CSF2 expression and megakaryocyte proliferation.
    Vieira L; Vaz A; Matos P; Ambrósio AP; Nogueira M; Marques B; Pereira AM; Jordan P; da Silva MG
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1093-108. PubMed ID: 22911897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of alkylating pyrrole-imidazole polyamide conjugates by a novel method for high-throughput sequencer.
    Kashiwazaki G; Maeda R; Kawase T; Hashiya K; Bando T; Sugiyama H
    Bioorg Med Chem; 2018 Jan; 26(1):1-7. PubMed ID: 29224995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx1 and Runx3 drive progenitor to T-lineage transcriptome conversion in mouse T cell commitment via dynamic genomic site switching.
    Shin B; Hosokawa H; Romero-Wolf M; Zhou W; Masuhara K; Tobin VR; Levanon D; Groner Y; Rothenberg EV
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33479171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.